Literature DB >> 36237635

Obesity influence on bladder inflammation and cancer: a cystitis model.

Cristiano Trindade de Andrade1, Guilherme Zweig Rocha1, Marina Zamuner1, Rodolfo Borges Dos Reis2, Leonardo Oliveira Reis3,1.   

Abstract

BACKGROUND: Recently, the role of subclinical inflammation in obesity has gained prominence. An association between obesity and chronic inflammation has been observed in several studies that show a relationship between increased morbidity and high Body Mass Index (BMI). This study aims to compare inflammatory pathways in obese (by high-fat diet) and non-obese mice after exposure to an intravesical carcinogen in a cystitis model.
METHODS: We divided 16 female, 7 week old mice into two groups: 1) CONTROL: standard diet, and 2) OBESE: high fat diet for 8 weeks. Both groups underwent a protocol for N-Nitroso-N-methylurea (MNU) pro-inflammatory bladder instillation. Bladder was analyzed by histopathology and western blotting for proteins of the inflammatory pathway (JNK, NFκB, c-JUN, IKK), and immunohistochemistry (proliferation and apoptosis).
RESULTS: While mice eating standard diet showed minimal histologic alteration in 4 of 5 (80%) bladder tissues, those eating a high fat diet showed moderate (60%) and intense (40%) chronic active inflammation with dysplasia foci, increased proliferation, apoptosis and inflammatory pathway activation with increased NFκB, and also IKKβ, JNK, and c-JUN phosphorylation in the urothelium.
CONCLUSION: A high-fat diet causes increased urothelial proliferation, apoptosis, and NFκB expression with cystitis exacerbation and dysplasia. Together, these results suggest that obesity induced by a high-fat diet increases the inflammatory pathway in the bladder with possible pre-malignant alterations. IJCEP
Copyright © 2022.

Entities:  

Keywords:  Inflammation; MNU; cancer; cystitis; mice; obesity

Year:  2022        PMID: 36237635      PMCID: PMC9547991     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  31 in total

Review 1.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

Review 2.  Inflammatory cytokines in bladder cancer.

Authors:  Pejman Shadpour; Mojtaba Zamani; Nazi Aghaalikhani; Nadereh Rashtchizadeh
Journal:  J Cell Physiol       Date:  2019-02-18       Impact factor: 6.384

Review 3.  Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.

Authors:  Neil M Iyengar; Ayca Gucalp; Andrew J Dannenberg; Clifford A Hudis
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

Review 4.  The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Authors:  Matteo Ferro; Daniela Terracciano; Carlo Buonerba; Giuseppe Lucarelli; Danilo Bottero; Sisto Perdonà; Riccardo Autorino; Alessandro Serino; Francesco Cantiello; Rocco Damiano; Iulia Andras; Sabino De Placido; Giuseppe Di Lorenzo; Michele Battaglia; Barbara A Jereczek-Fossa; Vincenzo Mirone; Ottavio De Cobelli
Journal:  Future Oncol       Date:  2016-09-14       Impact factor: 3.404

5.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

Authors:  Eli Pikarsky; Rinnat M Porat; Ilan Stein; Rinat Abramovitch; Sharon Amit; Shafika Kasem; Elena Gutkovich-Pyest; Simcha Urieli-Shoval; Eithan Galun; Yinon Ben-Neriah
Journal:  Nature       Date:  2004-08-25       Impact factor: 49.962

Review 6.  Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis.

Authors:  Wei Hong Wang; Jia Qing Huang; Ge Fan Zheng; Shiu Kum Lam; Johan Karlberg; Benjamin Chun-Yu Wong
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

7.  Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.

Authors:  Luis A Kluth; Evanguelos Xylinas; Joseph J Crivelli; Niccolo Passoni; Evi Comploj; Armin Pycha; James Chrystal; Maxine Sun; Pierre I Karakiewicz; Paolo Gontero; Yair Lotan; Felix K-H Chun; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  J Urol       Date:  2013-01-31       Impact factor: 7.450

Review 8.  Tumor associated macrophages and neutrophils in cancer.

Authors:  Maria Rosaria Galdiero; Eduardo Bonavita; Isabella Barajon; Cecilia Garlanda; Alberto Mantovani; Sébastien Jaillon
Journal:  Immunobiology       Date:  2013-06-17       Impact factor: 3.144

9.  An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.

Authors:  Matteo Ferro; Mihai Dorin Vartolomei; Giorgio Ivan Russo; Francesco Cantiello; Abdal Rahman Abu Farhan; Daniela Terracciano; Amelia Cimmino; Savino Di Stasi; Gennaro Musi; Rodolfo Hurle; Vincenzo Serretta; Gian Maria Busetto; Ettore De Berardinis; Antonio Cioffi; Sisto Perdonà; Marco Borghesi; Riccardo Schiavina; Gabriele Cozzi; Gilberto L Almeida; Pierluigi Bove; Estevao Lima; Giovanni Grimaldi; Deliu Victor Matei; Nicolae Crisan; Matteo Muto; Paolo Verze; Michele Battaglia; Giorgio Guazzoni; Riccardo Autorino; Giuseppe Morgia; Rocco Damiano; Ottavio de Cobelli; Shahrokh Shariat; Vincenzo Mirone; Giuseppe Lucarelli
Journal:  World J Urol       Date:  2018-07-10       Impact factor: 4.226

Review 10.  Interleukin-6 and its receptor in cancer: implications for translational therapeutics.

Authors:  David S Hong; Laura S Angelo; Razelle Kurzrock
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.